Advances in B Cell Biology: RA, SLE,
and Vasculitis
New Perspectives on B Cell
Immunobiology and Emerging B Cell
Therapies
Release Date: November 10, 2011
Expiration Date: November 10, 2012
 |
||
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Estimated Time of Completion: 30 minutes
Description
Advances in B Cell Biology: RA, SLE, and Vasculitis is a series of CME-accredited webcasts in which expert faculty bridge the gap between the complexities of current immunologic data and how they can be incorporated into clinical practice. The series is designed for busy clinicians interested in keeping abreast of cutting-edge data and novel therapies in treatment of ARDs – information that can have significant positive impacts on patient outcomes.
Learning Objectives
- Determine B cell-immune events that may be part of RA disease initiation.
- Distinguish the prognostic significance between B cell patterns of synovitis in RA.
- Establish potential connections in RA between B cells and bone remodeling.
- Describe the latest developments in B cell-targeted therapy in RA.
Target Audience
This activity is directed to rheumatologists, immunologists, allied health professionals, and other medical professionals who manage patients with rheumatic diseases.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, Ohio
Activity Director / Faculty
Gregg J. Silverman, MD
Co-Director, Musculoskeletal Center of Excellence
Professor of Medicine and Pathology
NYU School of Medicine
New York, New York
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), the Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:
| Leonard H. Calabrese, DO | ||
| Abbott Laboratories; Amgen; BMS; Centocor; Elan Pharmaceuticals, Inc.; Genentech/Roche; Pfizer; Wyeth | Consulting | |
| Abbott Laboratories; Amgen; Centocor; Genentech/Roche; Pfizer | Teaching and Speaking | |
| Gregg J. Silverman, MD | ||
| Biogen Idec; Genentech; Human Genome Science, Inc.; Roche Pharmaceuticals; Wyeth | Consulting | |
All other planners, CME staff, and content reviewers have no relevant financial relationships to disclose.
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:
Genentech & Biogen Idec
Human Genome Sciences, Inc.
This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education and
the R.J. Fasenmyer Center for Clinical Immunology.
